Play Video:
Johns Hopkins Diabetes Prevention and Education Program
Background
Dr. Mathioudakis is an endocrinologist, researcher, educator, and clinical leader. He has been honored numerous times as a Baltimore Top Doc, recognizing his commitment to patient care and expertise in diabetes management. He is a leading figure in diabetes research, having authored over 100 publications and contributed to consensus guidelines in the field. His pioneering studies have provided substantial insights into health informatics approaches for diabetes prevention and management.
Dr. Mathioudakis graduated from the Johns Hopkins University School of Medicine and trained in Internal Medicine at Johns Hopkins Bayview Medical Center. He completed a fellowship in Endocrinology, Diabetes, & Metabolism at the Johns Hopkins Hospital. Dr. Mathioudakis received his Master of Health Science degree in clinical investigation from the Johns Hopkins Bloomberg School of Public Health in 2015. In 2012, he became a member of the faculty in the Division of Endocrinology, Diabetes & Metabolism, where he served as the Clinical Director from 2016 to 2021. His current role as the Co-Medical Director of the Baltimore Metropolitan Diabetes Regional Partnership allows him to lead a comprehensive statewide initiative aimed at increasing patient access to diabetes prevention and self-management training programs.
Dr. Mathioudakis is the Principal Investigator of several NIH-funded studies. He is currently spearheading a clinical study to assess the effectiveness of a fully-automated diabetes prevention program compared to human coach-based diabetes prevention programs. Committed to ensuring equitable patient care, he is also leading a study to reduce racial disparities in access and use of advanced diabetes technologies. He also serves as the Principal Investigator for the T1D Exchange Quality Improvement Collaborative at the Johns Hopkins Adult Diabetes Center, where he works with a national network of healthcare providers to enhance the care and outcome of people with type 1 diabetes.
Dr. Mathioudakis holds a joint appointment in the Division of Biomedical Informatics and Data Science. He has published extensively on machine learning and AI applications in diabetes, allowing him to integrate cutting-edge technology into medical practice, improving healthcare outcomes and patient management through data-driven insights. Dr. Mathioudakis also served on the national Epic Endocrinology Specialty Steering Board for three years, where he played a pivotal role in defining the gold standard for electronic medical record adoption among endocrinology specialists across the country. From 2020-2023, Dr. Mathioudakis served as a Chair of the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. As part of an international team of experts, he has strived to advance precision medicine in diabetes care, paving the way for personalized treatment plans that can significantly improve patient outcomes.
Beyond his clinical practice and research, Dr. Mathioudakis is deeply committed to the education of future healthcare professionals. He is a frequent lecturer in various fields, including endocrinology, epidemiology, and data science.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.